p53 may positively regulate hepatocyte proliferation in rats

Hepatology

Volumn 36, Issue 2, 2002, Pages 336-344

  Inoue, Yukiko ^a   Tomiya, Tomoaki ^a   Yanase, Mikio ^a   Arai, Masahiro ^a   Ikeda, Hitoshi ^a   Tejima, Kazuaki ^a   Ogata, Itsuro ^a   Kimura, Satoshi ^b   Omata, Masao ^a   Fujiwara, Kenji ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA; MESSENGER RNA; PIFITHRIN ALPHA; PROTEIN INHIBITOR; PROTEIN P53; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; DNA SYNTHESIS; GENETIC TRANSCRIPTION; LIVER CELL; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; RAT; TUMOR SUPPRESSOR GENE;

EID: 18444374697     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.34942     Document Type: Article

References (50)

1. p53, the cellular gatekeeper for growth and division
2. The p53 pathway
3. p53 stimulates transcription from the human transforming growth factor alpha promoter: A potential growth-stimulatory role for p53
4. Wild-type human p53 activates the human epidermal growth factor receptor promoter
5. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53
6. Identification of an additional p53-responsive site in the human epidermal growth factor receptor gene promotor
7. Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter
8. Sequential protooncogene expression during rat liver regeneration
9. Hepatic regeneration
10. Liver regeneration: Molecular mechanisms of growth control
11. Hepatocyte growth factor. Its role in hepatic growth and pathology
12. Hepatocyte growth factor for liver disease
13. Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo
14. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats
15. Transforming growth α
16. Transforming growth factor a may be a physiological regulator of liver regeneration by means of an autocrine mechanism
17. Transforming growth factor-α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-α and hepatocyte growth factor
18. In vivo response of hepatocytes to growth factors requires an initial priming stimulus
19. Collagenase pretreatment and mitogenic effects of hepatocyte growth factor and transforming growth factor-α in adult rat liver
20. Transforming growth factor a levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration
21. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay
22. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients
23. Serum transforming growth factor α level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer
24. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor α levels
25. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure
26. The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous tranforming growth factor α
27. Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis and signal transduction of primary rat hepatocytes
28. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-α in rat liver epithelial cells
29. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
30. p53 antisense oligonucleotide inhibits growth of human colon tumor and normal cell lines
31. Nitric oxide-induced apoptosis: P53-dependent and p53-independent signalling pathways
32. Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents
33. Detection of transforming growth factor alpha in human urine and plasma
34. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing principle of protein-dye binding
35. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
36. Preparation of isolated rat liver cells
37. Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons
38. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases
39. Signal transduction in c-met mediated motogenesis
40. Phosphorylation of c-jun mediated by MAP kinases
41. Signal transduction within the nucleus by mitogen-activated protein kinase
42. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter
43. p53 expression and TGF-alpha-induced replication of hepatocytes isolated from rats exposed to the carcinogen diethylnitrosamine
44. Regulation of p53 stability by Mdm2
45. Mdm2 promotes the rapid degradation of p53
46. p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage
47. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
48. c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity
49. Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo
50. Regulation of cyclin-dependent kinase inhibitor p21 (WAF1/Cip1/Sdi1) gene expression in hepatic regeneration